drugset / Trial / NCT00509457
GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC)
Completed
20 enrolled
Oslo University Hospital
Sorlandet Hospital HF · collabSt. Olavs Hospital · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To examine the safety and efficacy of telomerase peptide vaccination ( stimulation of the immune system) in patients with NSCLC after having been treated with conventional therapy with radiotherapy and docetaxel as a radiosensitizer.
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TERTOMOTIDE | Vaccine | — | — |